Vicapsys Life Sciences, Inc. (VICP)
0.40
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Vicapsys Life Sciences Cash from Operations (Annual) : -0.0215M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.0215M |
| December 31, 2024 | -0.1217M |
| December 31, 2023 | -0.3671M |
| December 31, 2022 | -0.2382M |
| December 31, 2021 | -0.444M |
| December 31, 2020 | -0.2629M |
| December 31, 2019 | -0.9703M |
| December 31, 2018 | -2.089M |
| December 31, 2017 | -3.161M |
| Date | Value |
|---|---|
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | |
| December 31, 2011 | |
| December 31, 2010 | |
| December 31, 2009 | -1.394M |
| December 31, 2008 | -1.596M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |
| Sarepta Therapeutics, Inc. | -222.54M |
| Anixa Biosciences, Inc. | -7.173M |